Tirzepatide for PCOS and weight in women
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study tests if tirzepatide (a once-weekly injection) can improve periods and metabolic health in women with PCOS who are overweight. If you have PCOS, irregular cycles, and a BMI of 27 or higher, you might qualify.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18–45 with PCOS (diagnosed by a doctor) and have irregular periods or fewer than 8 periods a year.
- Your BMI is 27 or higher (overweight or obese).
- You are not pregnant, not planning pregnancy, and not breastfeeding during the 72-week study.
- You have not used GLP-1 weight-loss drugs (like Wegovy) or diabetes medications (like insulin) in the past 6 months.
- You are willing to stop hormonal birth control (like the pill) and use barrier methods (like condoms) for the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial examines how well tirzepatide works for weight loss in people with obesity, and how it's actually used in daily life. It may be an option if you haven't tried other obesity treatments and don't have diabetes.
This trial tests if tirzepatide, a weekly injection, can help people with type 1 diabetes who are also overweight or obese. The goal is to see if it improves blood sugar control and supports weight loss.
This study tests if tirzepatide helps people with obesity lose weight, whether or not they have type 2 diabetes. It aims to see how safe and effective the drug is.
This Phase 2 study tests whether tirzepatide can improve how your body handles fat (especially in people with overweight or obesity) and reduce fat-related “lipotoxicity.” It may help with body fat function and related health markers, but you must meet specific health and medication rules.
This trial tests if tirzepatide, a drug that helps with weight loss, can improve outcomes for women with obesity and certain early-stage endometrial conditions before a planned hysterectomy.
This trial tests a once-weekly injection called tirzepatide to help people with obesity and severe knee osteoarthritis lose weight and potentially reduce knee pain. It may be a good option if you're already waiting for knee replacement surgery and have struggled to lose weight in the past.
Hear when a new Polycystic Ovary Syndrome (PCOS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.